|
Melanoma Pancreatic Cancer Syndrome |
approved
|
606719 |
|
|
Melanoma, cutaneous malignant, susceptibility to, 10 (CMM10) |
approved
|
615848 |
|
|
|
|
Melanoma, cutaneous malignant, susceptibility to, 2 (CMM2) |
approved
|
155601 |
|
|
|
|
Melanoma, cutaneous malignant, susceptibility to, 3 (CMM3) |
approved
|
609048 |
|
|
|
|
Melanoma-Astrocytoma Syndrome |
approved
|
155755 |
|
|
|
|
MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes) |
approved
|
540000 |
|
|
Melnick Needles Syndrome |
approved
|
309350 |
|
|
|
|
Menkes disease |
approved
|
309400 |
|
|
Mental Retardation, autosomal recessive 65 |
approved
|
618109 |
|
|
|
|
Mental Retardation, X-linked, Syndromic 34, caused by NONO gene mutation (MRXS34) |
approved
|
300967 |
|
|
|
|
Mental Retardation, X-linked, syndromic, Claes-Jensen type (MRXSCJ) |
approved
|
300534 |
|
|
|
|
Merosin Deficient Congenital Muscular Dystrophy type 1A (MDC1A) (also known as LAMA2-related Muscular Dystrophy) |
approved
|
607855 |
|
|
|
|
Metabolic Crises, Recurrent, with Rhabdomyolysis, Cardiac Arrhythmias, and Neurodegeneration (MECRCN) |
approved
|
616878 |
|
|
|
|
Metachromatic Leukodystrophy (MLD) |
approved
|
250100 |
|
|
Metaphyseal Dysplasia without Hypotrichosis |
approved
|
250460 |
|
|
|
|
Methylmalonic Acidemia (MMA) |
approved
|
251000 |
|
|
|
|
Methylmalonic Acidemia cb1A |
approved
|
251100 |
|
|
Methylmalonic Acidemia cb1B |
approved
|
251110 |
|
|
|
|
Methylmalonic Aciduria and Homocystinuria |
approved
|
277400 |
|
|
Micro Syndrome (WARBM) |
approved
|
600118 |
|
